NIH Offers Commercialization Assistance to Phase ll Awardees

Deadline  for Applications: November 7, 2012

The purpose of this Notice is to announce the availability of a Commercialization Assistance Program (CAP) for NIH SBIR and STTR Phase II awardees. Now in its ninth year, this program is designed to help NIH SBIR and STTR Phase II awardees transition their developed products into the marketplace. Through a contract with Humanitas, Inc. of Silver Spring, MD with a sub-contract to Larta Institute of Los Angeles, CA, the CAP will provide early stage companies with individualized assistance toward accomplishing their commercialization goals.

Applications can be submitted starting on October 17th, 2012 and the deadline for submitting an application is November 7, 2012.  Seventy-five (75) companies will be selected to participate in this year’s NIH CAP (60 for CTT and 15 for ACT).

Detailed program information and application instructions are available at